Introduction
Proteasomes are large proteolytic complexes that play a central role in intracellular proteolysis and are particularly important for the tightly controlled degradation of many critical regulatory proteins (Ciechanover and Schwartz, 2004) . The term proteasomes defines a family of complexes, which share a common proteolytic core (the 20S proteasome) but differ in the regulators associated with the complex (Demartino and Slaughter, 1993; Rechsteiner and Hill, 2005) . This diversity of proteasome complexes might reflect the necessity for the cell to degrade hundreds of different proteins at the same time, often in a highly selective and regulated manner, and in certain cases only at precise locations in the cell (Pines and Lindon, 2005) . However, whether the activity of each of these complexes is restricted to a particular set of substrates or to particular cellular domains is presently unclear.
The 20S proteasome is a cylindrical-shaped protein complex, comprising 28 subunits arranged in four stacked rings: two outer rings each made of seven alpha-type subunits (α1 to α7) and two inner rings each made of seven beta-type subunits (β1 to β7). The catalytic sites are enclosed in the inner catalytic chamber made by the β-type subunits (Groll et al., 1997) . In cells, the 20S proteasome is found associated with a variety of regulators that modulate its functions. The best understood 20S regulator is the 19S complex, which binds in an ATP-dependent manner to both ends of the 20S cylinder to form the 26S proteasome that is, in particular, involved in the degradation of ubiquitylated proteins (Coux et al., 1996; Voges et al., 1999) . The 20S proteasome can also associate with a variety of other regulators (DeMartino and Slaughter, 1999) , including PA200 (Ortega et al., 2005) and the complexes of the PA28 family, PA28α/β and PA28γ (Rechsteiner and Hill, 2005) , to form other proteolytic complexes that likely carry out specific functions. PA28α/β is a heptamer of the two closely related PA28α and PA28β subunits (Whitby et al., 2000) . It can bind to both ends of 20S proteasome (Gray et al., 1994) , and also be integrated into "hybrid proteasomes" in which one molecule of 19S complex and one molecule of PA28α/β are bound at each end of 20S proteasome (Cascio et al., 2002) . PA28α/β is essentially cytoplasmic and, in vitro, has been shown to stimulate the peptidase, but not the protease, activities of the 20S proteasome (Ma et al., 1992) . It is thought to play an important role in the production of MHC class I antigenic peptides (Groettrup et al., 1996) . PA28γ, initially called "Ki antigen", is similar to PA28α and β (Kandil et al., 1997; Tanahashi et al., 1997) , but forms only homoheptamers and is mostly nuclear. Its functions are poorly characterized, but studies in mice (Murata et al., 1999; Barton et al., 2004) and flies (Masson et al., 2003) suggest a role for this complex in cell cycle progression and apoptosis. Furthermore, PA28γ has been recently identified as a key player in the degradation of the oncogene SRC-3 (Li et al., 2006) and of the CKI p21 (Chen et al., 2007; Li et al., 2007) , and was shown to act as a novel regulator of Cajal Bodies integrity under genotoxic stress (Cioce et al., 2006) .
To better understand the specific functions of the various proteasome complexes, it is important to know where in the cells each type of complex is present and active. However, in most previous studies of proteasome localization, only immunofluorescence analyses of the 20S proteasome have been conducted, and it was not known whether the fluorescence corresponded to free 20S or 20S bound to the 19S complex (i.e. the 26S proteasome), or to other regulators. In general, the 20S proteasome appears distributed in both cytoplasmic and nuclear compartments (Reits et al., 1997; Wojcik and DeMartino, 2003) , and most of it is found in the soluble fraction after cell lysis. A small percentage, however, seems to be associated with defined cellular structures. In the cytoplasm, the 20S proteasome is found associated with the cytoskeleton (Grossi de Sa et al., 1988) , the endoplasmic reticulum (Brooks et al., 2000) and with a perinuclear structure that coincides with the centrosome (Wigley et al., 1999) . In the nucleus, the 20S proteasome is found in distinct nuclear regions, including PML bodies Wojcik and DeMartino, 2003) and nuclear speckles Rockel et al., 2005) .
Nuclear speckles (NS), also called interchromatin granule clusters (IGCs), correspond to subnuclear domains enriched in components of the pre-messenger RNA splicing machinery such as the SR protein family Rockel and von Mikecz, 2002; Lamond and Spector, 2003; Rockel et al., 2005) . They are highly dynamic domains with a constant in/out shuttling of splicing factors that undergo post-translational modifications (particularly phosphorylation/dephosphorylation) necessary for their subsequent recruitment at transcription sites (Misteli et al., 1998) . Indeed, disassembly of NS leads to dramatic reduction of accumulation of splicing factors at transcription sites and perturbs coordination between transcription and splicing (Sacco-Bubulya and Spector, 2002) . The presence of proteasomes in NS, together with the fact that proteasome inhibitors promote the accumulation of SR protein SC35 in NS , suggests that, as with phosphorylation, proteolysis might be intrinsically involved in the control of the intranuclear trafficking of splicing factors and their repartition between NS and transcription sites.
In this study, we show that a specific form of proteasomes (i.e. 20S proteasome-PA28γ complexes) is present in the NS in an active form. Also, we demonstrate that a reduction of PA28γ expression by siRNA triggers a profound alteration of nuclear speckles organization and affects the recruitment of SR proteins to transcription sites
Materials and Methods

Antibodies and compounds
Antibodies against GFP were obtained from Roche Diagnostic. Antibodies against α3 (PW8115), α4 (PW8120), α6 (PW8100), α7 (PW8110), Mss1/Rpt1 (PW8825) Sug1/Rpt6 (PW9265), PA28γ (PW8190) and PA28β (PW8280) were purchased from Affiniti Research Products Ltd., and antibodies against SC35 (S4045), SF2/ASF (32-4500) and HA (12CA5) were purchased from Sigma, Zymed and Roche Diagnostic, respectively. Alexa and HRP-conjugated secondary antibodies were purchased respectively from Interchim and BioRad SA. Suc-Leu-Leu-Val-Tyr7amido-4-methylcoumarin (suc-LLVY-AMC, Bachem Biochimie SARL), MG132 (Boston Biochem), DRB (Sigma) and Actinomycin D (Sigma) were dissolved in DMSO. DQ-Ovalbumin was purchased from Calbiochem.
Plasmid constructs and siRNA
Human cDNA (768 bp) encoding the full-length α7, with or without the final stop codon, was amplified from a human fibroblast cDNA library by PCR and inserted into pcDNA 3 or pML1-ECFP vectors and verified by sequencing. The cDNA coding for α7-ECFP and ECFP were then inserted into pTRE2 vector (Clontech). The pEGFP-hSC35, pcDNA 3 -Tat and pEGFP-SF2/ASF constructs were generated in the laboratory of J. Tazi and E. Bertrand, respectively. To construct mammalian expression vectors for BiFC analyses, sequences encoding amino acids 1-154 of Enhanced Yellow Fluorescent Protein (EYFP) (N-terminal fragment [YN] ) and amino acids 155-239 of EYFP (C-terminal fragment of YFP [YC]) were cloned into pcDNA 3 . Full-length α7 cDNA (without the final stop) was inserted in pcDNA 3 -YN and full-length PA28γ cDNA in pcDNA 3 -YC to create α7-NY and CY-PA28γ fusion proteins, respectively. siRNA duplexes against human PA28γ were purchased from Ambion (PSME3, ID#: 138669) (siRNA#1) or MWG (siRNA#2) (Cioce et al., 2006) . Scrambled duplexes (Silencer TM negative control#1) were purchased from Ambion. A PA28γ construct resistant to the siRNA #2 was made by mutation of six nucleotides in PA28γ cDNA subcloned in pcDNA 3 -3HA vector.
Cell culture and transfection
HeLa cells (ATCC), U 2 OS-tTA (Theis-Febvre et al., 2003) , 2E11 cell line (Boireau et al., 2007; du Chéné et al., 2007) and MelJuso cell line expressing constitutively the LMP2-GFP fusion protein (Reits et al., 1997) were cultured as described in the respective papers. U 2 OS-tTA cells expressing stably α7-CFP or CFP were established as described (Theis-Febvre et al., 2003) .
Plasmid transfections in cells were carried out using the JetPEI TM reagent (Qbiogene). 25 nanomoles/ml of each siRNA were transfected into cells with the oligofectamine reagent (Invitrogen), following manufacturer's instructions.
Immunoprecipitation and immunoblot analysis
Cells were lysed for 15 min at 4°C in lysis buffer (50 mM Tris pH-HCl 8.0, 5 mM MgCl 2 , 0.5 mM EDTA, 1 mM ATP, 1 mM DTT, 10% glycerol, 0.5% IGEPAL CA630). This treatment does not solubilize NS components (not shown), which can be later solubilized using a buffer containing 0.3% Triton X-100. Lysates were clarified by centrifugation for 10 min at 10,000 x g, and the protein concentration of the supernatant was determined using BSA as a standard (Bradford reagent assay, Pierce). Total lysate (200 µg) was pre-cleared for 30 min and immunoprecipitations were performed using 3 µl of indicated antibodies and Protein A or G magnetic beads (Dynal) in lysis buffer containing 100 mM NaCl. After several washes, bead pellets were boiled in SDS sample buffer, separated by SDS-PAGE and transferred to nitrocellulose membranes. Immunoblotting was performed as described previously (Baldin et al., 1993) . Visualization was performed by enhanced chemiluminescence (Perkin Elmer).
Proteasome activity assay
Proteasome activity was measured on beads of immunopurified proteasome by incubation at 37°C for 20 min in 100 µl of activity buffer (20 mM Tris-HCl pH 7.5, 5 mM MgCl 2 , 1 mM ATP, 1 mM DTT, 10 % Glycerol) containing 100 µM suc-LLVY-AMC. The fluorescence of the free AMC generated by proteasome activity (λ ex = 380 nm, λ em = 440 nm) was measured on a spectrofluorimeter (Perkin Elmer). Proteasome activity in living cells was analyzed in U 2 OS cells as described (Rockel et al., 2005) .
Indirect immunofluorescence
Cells were transfected or not with expression vectors encoding the mentioned cDNAs. At indicated times after the transfection and/or induction, cells were fixed using 3.7% formaldehyde, then permeabilized with 0.25% Triton-X100 and cold methanol. Proteasome subunits were detected by incubating the cells with the first antibody, followed by a second incubation with Alexa-594 or 488 conjugated goat anti-mouse (or anti-rabbit) antibody (1:1000) (Molecular Probes). In all cases, DNA was stained with DAPI dye (Sigma). In situ hybridization was performed as described (Verheggen et al., 2002) . Microscopic examinations were performed with a 63X/1.32 NA or 100X/1.4 NA oil immersion objective lens under a Leica DMRA microscope and a 12-bit Micromax YHS 1300 camera. Images were acquired as TIF files using the MetaMorph 6.2 imaging software.
Fluorescence recovery after photobleaching
FRAP analyses were performed at 37°C on HeLa cells transiently expressing α7-GFP with a laser scanning microscope (Zeiss LSM Meta 510). The argon laser spectral line (wavelength of 488 nm) was set to an intensity not greater than 0.3% of its total power (458, 477, 488, 514, 30 mW) for image collection. A 40X/1.2 NA water immersion objective was used. After 12 prebleach scans (1 scan/s), a region of interest (ROI) was photobleached using 15 iterations at 3 mW laser power. 12-bit images were collected before, immediately after, and at defined intervals after bleaching (once every 0.8 second). Our total experiment time was set to 130 s., which was sufficient for complete recovery from photobleaching. The mobile fraction (R) was determined using the formula: R = (F• -F0)/(Fi-F0). τ 1/2 was directly read off of the graph as the time when fluorescence had recovered by 50%.
RT-PCR
Total RNA was extracted using the Mini RNA isolation II kit (ZYMO Research). 1 μg of RNA was reverse-transcribed using the first-strand cDNA synthesis kit (GE Healthcare) according to the supplier specifications. cDNAs were amplified with the Taq polymerase (Invitrogen) using specific primers corresponding to S26 and artificial gene mRNA (100 and 193 nucleotides, respectively).
Results
Ectopically expressed proteasome α7 subunit accumulates into nuclear foci
To study the subcellular localization of the 20S proteasome in living cells, and to avoid overproduction of the protein by transient expression, we established stable U 2 OS-tTA cell lines expressing 20S α-subunits in fusion with CFP, under an inducible promotor (tet-off). In the tested cell lines, exogenous α-CFPs were expressed at a level similar to that of endogenous α proteins ( Figure 1A ) (α7-CFP as an example). Surprisingly, in addition to the relatively even cytoplasmic and nuclear distribution of α7 detected by indirect immunofluorescence in parental U 2 OS-tTA cells, distinct nuclear foci were apparent in α7-CFP expressing cells ( Figure 1B ) (compare panel endogenous α7 to panel ectopic α7-CFP), which contrasted with the images obtained with cell lines expressing other tagged subunits such as α3-CFP (not shown) or LMP2 (Reits et al., 1997) .
Importantly, despite the apparent brightness of the α7-CFP containing foci, quantification of the fluorescence using the Metamorph software showed that α7-CFP containing foci represent only 7.7% of the total cellular α7-CFP and 22% of the nuclear α7-CFP.
Although this peculiar distribution could reflect the presence of aggregates accumulating upon expression of the CFP-tagged subunit, several lines of evidence indicated that this was not the case. Firstly, we observed that this effect was independent of the presence of the CFP moiety on the subunit: expression of unmodified α7 protein also gave rise to accumulation of the subunit into similar nuclear foci ( Figure 1B , right panel). Secondly, upon prolonged induction of the α7-CFP protein, no defect on cell cycle progression could be detected (data not shown), as it would be expected if proteasome function was altered. Thirdly, we observed that the distribution of α7-CFP dramatically changed during mitosis: α7-CFP diffused throughout the cell during metaphase and reformed foci in telophase ( Figure S1 ). In addition, gel filtration analysis of extracts from U2OS-α7-CFP cells revealed the presence of α7-CFP protein only in fractions containing proteasomes (data not shown). Altogether, these experiments indicate that α7-CFP-containing nuclear foci are not aggregates. Furthermore, FRAP (Fluorescence Recovery After Photobleaching) (White and Stelzer, 1999) analysis of the mobility of α7-GFP showed that, after laser-photobleaching of α7-GFP nuclear foci, the mobile fraction of α7-GFP corresponded to 77% (+/-2.9%) of the protein present in the foci, and that the half time (τ 1/2 ) of complete α7-GFP recovery in the bleached area was 5.75 s (+/-1.43). This recovery rate is considerably slower than that of GFP alone (τ 1/2 = 0.3 s, see Kruhlak et al., 2000) , but equivalent to that of many other mobile nuclear proteins, including transcription factors and RNA splicing components such as SR proteins (τ 1/2 = 3-6 s (Phair and Misteli, 2000) ), showing that α7-CFP localization into nuclear foci is in fact dynamic.
Biochemical experiments indicated that α7-CFP was readily incorporated into proteasomal complexes ( Figure 2 ). Immunoprecipitation on whole cell extracts demonstrated the presence of other 20S proteasome subunits (α6 subunit) as well as 19S complex subunits (Sug1 protein, an
ATPase of this complex) in anti-GFP immunoprecipitates and showed that α7-CFP is also present in anti-Sug1 immunoprecipitates ( Figure 2A ). The immunoprecipitated CFP-containing
complexes were proteolytically active when tested against the proteasome substrate suc-LLVY-AMC ( Figure 2B , right panel). Morever, using an in situ proteasome-dependent proteolysis assay (Rockel et al., 2005) , based on the microinjection of a fluorogenic substrate (DQ-ovalbumin (DQ-OVA) into the cell nucleus, we demonstrated that α7-CFP complexes were active in the nuclear foci. After microinjection of DQ-OVA in parental U 2 OS cell nuclei, we confirmed that its degradation (monitored by the appearance of fluorescence) occurs throughout the nucleoplasm but also in discrete foci, as previously published (Rockel et al., 2005) ( Figure 2C , upper panel).
However, in U 2 OS cells expressing ectopic α7, the fluorescent foci resulting from DQ-OVA degradation colocalized completely, in number and shape, with α7 positive nuclear foci ( Figure   2C , lower panel). Based on these observations, it can be concluded that the proteasomes complexes containing α7-CFP protein are active in protein degradation.
Finally, we found that whole 20S proteasomes were present in α7-CFP containing nuclear foci:
indirect immunofluorescence showed that in contrast to the diffuse nuclear localization observed in U 2 OS parental cells ( Figure 3A ), other tested 20S subunits, namely α4 and α6, localized into the same nuclear foci upon α7 expression ( Figure 3B ), without any significant variations of their cellular level ( Figure 3C ). Altogether, these data show that ectopic expression of α7 at moderate level entails recruitment to nuclear foci of genuine, active proteasome complexes, and not accumulation of free α7.
Identification of the nuclear foci as the nuclear speckles
A critical point was to define the nature of the nuclear foci evidenced by expression of α7-CFP.
As previous reports described that 20S proteasomes localized to subnuclear domains such as PML bodies Wojcik and DeMartino, 2003) or nuclear speckles (NS) (Chen et al., 2002; Rockel and von Mikecz, 2002) , we analyzed by indirect immunofluorescence the potential colocalization of α7-CFP with markers of those two nuclear subdomains, using antibodies raised against PML and SR proteins. Whereas the nuclear foci were clearly distinct from the PML bodies (data not shown), we observed a complete colocalization of α7-CFP with SC35 protein ( Figure 4A ), a member of the SR protein family that is concentrated in nuclear speckles Lamond and Spector, 2003) . To verify that the localization of α7-CFP in NS was not a coincidence, we treated the cells with transcriptional inhibitors (actinomycin D and DRB) that cause NS to enlarge and round up (Spector, 1993) (for a review, see Lamond and Spector, 2003) . In these cases, we observed similar morphological changes for the foci labeled by α7-CFP and SC35 ( Figure 4B ), indicating that proteasome complexes containing α7-CFP and NS are tightly connected.
20S proteasome-PA28γ complexes, but not 26S proteasome complexes, are recruited to NS upon α7 expression
To determine to which regulator(s) the 20S proteasome was associated with in the NS, we performed indirect immunofluorescence analyses using specific antibodies raised against components of different regulatory complexes. Whereas colocalization of α7-CFP and two ATPases (Mss1 and Sug1) of the 19S regulator of the 20S proteasome could be detected in both the cytoplasm and the nucleus of the cells, these ATPases did not accumulate together with α7-CFP into the NS, unlike the α4 subunit of the 20S proteasome ( Figures 5A and S2A and B).
These results indicate that 26S proteasome is not the proteasomal complex recruited to the NS upon α7 ectopic expression. We thus tested for the presence of other regulators of the 20S
proteasome. Strikingly, in U 2 OS cells expressing α7-CFP, PA28γ accumulated with α7 (and thus with 20S proteasomes) in these foci (Figures 5B and S2A and B) , whereas, in contrast, the related regulator PA28α/β did not ( Figure 5A , lower panel). We also noted that, during mitosis, when the foci reversibly redistribute throughout the cell, the localization of PA28γ strictly followed that of α7-CFP containing 20S proteasome ( Figure S1 ).
Together, these experiments show that ectopic expression of α7 (-CFP) entails accumulation into the NS of 20S proteasome-PA28γ complexes, which are active in protein degradation ( Figure   2C ). This accumulation is specific for this type of proteasome complex, since the 19S regulatory complex of the 20S proteasome, visualized here by following its Sug1 and Mss1 subunits, is not recruited in the NS, even though α7-CFP-containing 20S proteasomes can associate to the 19S complex elsewhere in the cells, as shown by co-immunoprecipitation experiments (Figure 2A and B).
We confirmed the interaction between α7-CFP-containing 20S proteasome and PA28γ in cell extracts by co-immunoprecipitation from mildly solubilized (S1 fraction, no extraction of α7-CFP nuclear foci) or triton-solubilized cell extracts (S2 fraction, obtained after solubilization of α7-CFP nuclear foci) using antibodies directed against either α7, GFP or PA28γ ( Figure 6A ).
Even though the majority of 20S proteasome-PA28γ complexes was present in the S1 fraction, the complexes were also present in the S2 fraction enriched in NS ( Figure 6A) , and were active when tested for degradation of the proteasomal peptide substrate Suc-LLVY-AMC (data not shown). Notably, the distribution of the complexes between the S1 and S2 fractions is in agreement with the low percentage of α7-CFP present in the nuclear foci, estimated by fluorescence quantification (see above). We then used the Bimolecular Fluorescence
Complementation (BiFC) technique to evaluate directly, in cellulo, the ability of α7 to interact with PA28γ in the NS. This technique is based on the fact that the YFP chromophore can be reconstituted in cells when two chimeric proteins, each harboring half of the chromophore, interact (Kerppola, 2006) . When α7 fused to the C-terminal half of YFP (α7-CY) was coexpressed in cells with PA28γ fused to the N-terminal half of YFP (NY-PA28γ), the fluorescence could be reconstituted throughout the nuclei, with a marked accumulation in nuclear foci, which most likely correspond to NS ( Figure 6B ). Interaction was also observed in the nucleus between molecules of PA28γ, as expected since PA28γ forms heptamers, and curiously between molecules of α7 as well ( Figure 6B ) (see discussion). Together, these results confirm the in cellulo interaction between 20S proteasome and its PA28γ regulator and strongly suggest that 20S proteasome-PA28γ complexes are indeed present in the NS.
PA28γ is present in the nuclear speckles without expression of α7-CFP
To exclude the possibility that the localization of 20S-PA28γ complexes in the NS was only due to α7 ectopic expression, we examined the localization of PA28γ in parental U 2 OS cells. Since in fixed cells no clear specific intra-nuclear localization of PA28γ could be detected, soluble PA28γ was removed by simultaneous fixation and permeabilization of the cells. Under these conditions, we clearly visualized the colocalization of the remaining endogenous PA28γ with SC35 protein in the NS ( Figure 7A ). Therefore, 20S-PA28γ complexes are present in the NS without α7 ectopic expression, although their NS localization is strongly enhanced by it. Curiously, we were unable to detect the endogenous 20S proteasome in the NS, even when different conditions of permeabilization and various antibodies were used, although these complexes have been seen previously by others in the NS Rockel et al., 2005) . However, we could vizualize a physical interaction between 20S proteasome and SR proteins in coimmunoprecipitation experiments using extracts from cells expressing α7 and SF2/ASF-GFP proteins ( Figure 7B ). By contrast, SF2/ASF was not detected in anti-PA28γ immunoprecipitates, possibly because the PA28γ epitope was masked by the interaction with SF2/ASF-GFP.
Roles of 20S proteasome-PA28γ complexes in the structural integrity of the NS
The results described above demonstrate for the first time that 20S proteasome-PA28γ complexes are present in the NS and suggest a specific role of these complexes in this subnuclear domain.
To gain insight into this role, we investigated the effect of the absence of 20S-PA28γ complexes, using siRNA duplexes directed against PA28γ. Because the complete absence of PA28γ appeared to be toxic to our cells, we could only analyze a partial knockdown of PA28γ (decreased approximately 70% from its normal level) ( Figure 8A ). Very interestingly, we observed that in 8D ) and SF2/ASF ( Figure 8E ), or exogenous SF2/ASF-GFP ( Figure 11A ), was analyzed by immunofluorescence, the same structural alteration of the NS was observed, showing that not only the distribution of the proteasome, but that of the entire NS population was affected by PA28γ knockdown. Importantly, ectopic expression of α7 was not required for these effects, since the same alteration of the NS was observed in parental U 2 OS cells ( Figure 8F ) upon PA28γ knockdown. Moreover, the same results were obtained using a second siRNA duplex (siRNA# 2) ( Figure 9A and B), directed against another PA28γ mRNA region and already validated in a previous study (Cioce et al., 2006) . Importantly, the effect of this siRNA was reversed by coexpression of a construct resistant to the siRNA ( Figure 9B ). Therefore, alteration of the NS is clearly due to PA28γ depletion, showing that endogenous 20S-PA28γ complexes are necessary for typical NS organization in U 2 OS cells.
To test whether the effect of PA28γ knockdown was restricted to the NS, we analyzed by indirect immunofluorescence the organization of other known nuclear domains such as PML bodies and Cajal Bodies (CB) (Figure 10 ). In cells treated with PA28γ−siRNA, no changes were observed in PML bodies ( Figure 10B ) or in the number and appearance of CBs detected by anti-TGS1 (TrimethylGuanosine Synthase) or anti-SMN antibodies ( Figure 10A , upper panels). However, we noticed a redistribution of coilin (an autoantigen marker of CBs). In cells knocked down for PA28γ, coilin was still present in the CBs, but appeared additionally in other nuclear regions ( Figure 10A , lower panel). Most likely, the partial delocalization of coilin was due to the fact that PA28γ plays a role in its nuclear distribution (Cioce et al., 2006) . Altogether, our results suggest that PA28γ knockdown does not alter the whole nuclear organization but impacts mostly NS integrity, even though it is clear that PA28γ must have functions outside the NS.
NS are known to be highly dynamic structures in which splicing factors undergo posttranslational modifications (particularly phosphorylations) that are required for the SR proteins to leave the NS and be subsequently recruited at transcription sites (Misteli et al., 1998) . We thus tested whether knockdown of PA28γ altered the capacity of SR proteins to be recruited at a specific transcription site. For this purpose, we used the 2E11 (also called pU2OS_Exo1) cell line, a derivated U 2 OS cell line that harbors an integrated inducible HIV-1 reporter gene containing a splice site for SF2/ASF. An additional RNA tag (MS2) was inserted to facilitate its visualization by in situ hybridization (Boireau et al., 2007; du Chéné et al., 2007) . The ability of SF2/ASF to be recruited to nascent pre-mRNAs was estimated by measuring the relative level of the protein at the transcription site (TS, visualized as a nuclear dot by in situ hybridization with a MS2-Cy3 probe) compared to its level at a neighboring NS ( Figures 11A and S3) . To eliminate the variation of GFP level, due to transfection efficiency, only loci of cells presenting a similar level of SF2/ASF-GFP in NS were scored. Results were summarized in the histogram shown in Figure 11B . In untreated cells or with control-siRNA treatment, the level of SF2/ASF-GFP at the TS was generally higher than in the NS, reflecting the normal recruitment of SF2/ASF-GFP to TS. In contrast, with PA28γ-siRNA treatment, the level of SF2/ASF-GFP at the TS was most of the time lower than at the NS without affecting the transcription level of the artificial gene ( Figure 11C ). These results show that under PA28γ-siRNA treatment, the recruitment of SR proteins to the active TS is largely reduced, although not abolished.
Together, these experiments demonstrate that 20S proteasme-PA28γ complexes play an important role in NS organization and dynamics and mediate a process involved in the regulation of accumulation and/or targeting of splicing factors to transcription sites.
Discussion
We show here that active 20S proteasome-PA28γ complexes are present in the NS, and that reduction of PA28γ levels, using siRNA, dramatically alters NS organization and nuclear trafficking of splicing factors. Our data thus demonstrate a new role of 20S-PA28γ complexes in nuclear organization, and provide novel important information for our understanding of both the specific functions and localization of the various forms of proteasomes and the regulation of NS structure and dynamics.
Our discovery originates from the serendipitous observation that ectopic expression of the proteasomal α7 subunit triggers accumulation of 20S proteasome-PA28γ complexes in the NS.
This observation raises the intriguing and puzzling problem of how this effect is mediated. One possibility was that overexpression of α7 led to an increase of the cellular concentration of 20S
proteasome, but we found no evidence to support this supposition. One alternative hypothesis is that α7 ectopic expression entails incorporation of more than two α7 subunits into individual 20S proteasome complexes. Indeed, some plasticity in proteasome assembly has been documented in yeast, in which α3 could be replaced by α4 (Velichutina et al., 2004) . In this respect, it is remarkable that α7 seems to possess a greater propensity to interact to PA28γ than other subunits.
When we used the proteasome subunit α3, no interaction with PA28γ could be detected by BiFC, contrary to the result obtained for α7, suggesting that (i) PA28γ does not interact identically with all α subunits of the proteasome and (ii) within the 20S proteasome, the α7 subunit possesses certain sequence and/or structural features that makes it a favored partner for PA28γ. Thus, a proteasome with more than one α7 subunit per α-ring could either have a higher affinity for PA28γ, or impose a particular conformation to the complex formed with PA28γ, two mechanisms that in turn could impact on the steady-state nuclear distribution of the 20S-PA28γ complex.
In any case, even if the exact reasons for accumulation of 20S-PA28γ in NS upon α7 ectopic expression remain to be elucidated, several arguments show that the presence of 20S-PA28γ complexes in the NS is physiologic, albeit not easily detectable normally. In particular, the presence of active 20S proteasome in the NS, as previously documented by others (Rockel et al., 2005) , together with our results demonstrating that (i) PA28γ can be detected in the NS without ectopic α7 expression, (ii) knockdown of endogenous PA28γ alters NS morphology, and (iii) 20S
proteasomes can interact with PA28γ in the NS (as illustrated by colocalization, affinity purification and in vivo interaction (BiFC)), demonstrate that these complexes constitute an important active form of the proteasome in the NS.
Regarding the function(s) of 20S-PA28γ complexes in the NS, it is most likely that these complexes mediate the local degradation of specific proteins, even though they certainly have other substrates in other nuclear regions. We hypothesized that substrates of 20S-PA28γ complexes in the NS could be the SR proteins themselves since it has been reported that the intrinsic NS component SC35 is stabilized by proteasome inhibitors . However, in our cells, expression of α7-CFP or knockdown of PA28γ did not alter the half-life of SC35 (data not shown). Other attractive substrates for 20S-PA28γ complexes are kinases or phosphatases present in the NS (Colwill et al., 1996; Misteli and Spector, 1996; Wang et al., 1998; Ko et al., 2001) . Indeed, these enzymes control the phosphorylation status of SR proteins and thereby their recruitment at transcription sites (Misteli et al., 1998) . Thus, alteration of the expression level of one or several of these enzymes could explain the alteration of both the morphology of the NS and the recruitment of SR proteins to transcription sites seen upon PA28γ knockdown. Obviously, to understand the role(s) of 20S-PA28γ complexes in the NS, an important development for the future will be to identify their nuclear substrates, particularly those localized in the NS.
Nevertheless, even without this information, our observations provide additional demonstration that, within the family of proteasome complexes, 20S proteasome-PA28γ complexes have specific functions in the cell nucleus. Until recently, the functions of PA28γ have remained quite elusive. Genetic manipulations in mice and Drosophila have suggested that it might be involved in cell cycle progression and have anti-apoptotic functions (Rechsteiner and Hill, 2005) .
However, its exact role in these processes is not understood. Biochemical analyses have shown that PA28γ can activate peptide degradation by the 20S proteasome in vitro (Realini et al., 1997) , but it has been demonstrated only recently that PA28γ is indeed involved in the degradation of proteins, namely the HCV (Hepatitis C virus) core protein (Moriishi et al., 2003) , the SRC-3 oncogene and the CKI p21 (Li et al., 2006; Chen et al., 2007; Li et al., 2007) . PA28γ has also been identified as a novel regulator of Cajal Bodies integrity (Cioce et al., 2006) , but it was unclear in this case whether 20S proteasome was required for this process. We now additionally show that 20S-PA28γ complexes are involved in the control of nuclear trafficking of splicing factors, since reduction of PA28γ levels by siRNA strongly perturbs NS morphology and impairs recruitment of SR proteins (SF2/ASF) at transcription sites. The physiologic importance of this role is presently unclear, since knockdown of PA28γ did not appear to affect transcription (as evaluated by RT-PCR of a specific gene (Figure 11C ), or globally by 5-FU incorporation ( Figure   S4A )), nor to impair globally the specificity of the splicing machinery, since no variations were detected on various endogenous and transfected genes subjected to alternative splicing ( Figure   S4 , B and C). Our results are similar to previously described data Misteli et al., 1998) showing that an SF2/ASF mutant (Δ−RS) was able to perform alternative splicing in vivo, in a manner very similar to the wild type, in absence of its recruitment to transcription sites, and suggesting that recruitment to the TS does not always reflect the functional properties of splicing factors. However, one possibility in our case is that the low level of SF2/ASF still present at TS is in fact sufficient for normal splicing.
Another question arising from our data is how 20S-PA28γ complexes are targeted to the NS. Our FRAP analyses demonstrated that α7-GFP (and therefore the proteasome) mobility is high in the NS, indicating that the complexes shuttle into and out of the NS. Currently, the mechanism of the targeting of the complex to the NS is unclear, as neither proteasome subunits nor PA28γ display signature motifs of NS proteins, such as RS domains, for example. Possibly, protein(s) binding to 20S proteasome and/or PA28γ could act as adaptor(s) facilitating the docking of the complex to the NS. Interestingly, since we detected a physical interaction between the 20S proteasome and SF2/ASF, SR proteins themselves could be responsible for targeting proteasomes to the NS.
In conclusion, the data presented here demonstrate that 20S proteasome associated with its PA28γ regulator plays a critical role in the NS since it appears necessary for their structural organization and for intranuclear trafficking of splicing factors. Our data also suggest that the specificity of proteasome-dependent proteolysis, which is often considered as being regulated at the level of the ubiquitylation, can be controlled by complex mechanisms operating at the level of the proteasome and its intracellular localization. Further analysis of the role of 20S proteasome-PA28γ complexes in the NS should provide new information on the mechanisms involved in the control of nuclear organization. Our results highlight a novel layer of complexity in the regulation of NS architecture and function, as well as SR protein trafficking, and suggest that intracellular proteolysis is intrinsically involved in the regulation of nuclear plasticity. 
